Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
245.44
+6.57 (2.75%)
Dec 20, 2024, 4:00 PM EST - Market closed
Alnylam Pharmaceuticals Revenue by Segment
History
| Date | Amvuttra | Givlaari | Collaboration | Onpattro | Oxlumo | Royalty |
|---|---|---|---|---|---|---|
| Sep 30, 2024 | 859.20M | 250.50M | 479.60M | 275.70M | 156.10M | 73.40M |
| Jun 30, 2024 | 749.30M | 233.60M | 849.70M | 307.00M | 144.60M | 59.90M |
| Mar 31, 2024 | 651.30M | 229.40M | 628.20M | 321.30M | 128.20M | 44.70M |
| Dec 31, 2023 | 557.90M | 219.20M | 546.20M | 354.60M | 109.80M | 40.60M |
| Sep 30, 2023 | 451.20M | 207.00M | 540.40M | 397.80M | 100.90M | 26.30M |
| Jun 30, 2023 | 327.70M | 198.60M | 142.20M | 461.20M | 88.60M | 19.10M |
| Mar 31, 2023 | 195.60M | 185.90M | 145.40M | 523.10M | 79.30M | 14.20M |
| Dec 31, 2022 | 93.80M | 173.30M | 134.80M | 557.60M | 69.70M | 8.10M |
| Sep 30, 2022 | 25.20M | 166.90M | 123.80M | 574.00M | 65.10M | 5.80M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.